Sort   by:  
 Page size 
UnknownIn Vitro Exposure of Leukocytes to HIV Preexposure Prophylaxis Decreases Mitochondrial Function and Alters Gene Expression Profiles.
Not available
S-EPMC7927818 | biostudies-literature
UnknownPhase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampin.
Not available
S-EPMC4135849 | biostudies-literature
UnknownEfficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.
Not available
S-EPMC4412467 | biostudies-literature
UnknownThe F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial.
Not available
S-EPMC4753889 | biostudies-literature
UnknownPitavastatin to Prevent Cardiovascular Disease in HIV Infection.
Not available
S-EPMC10564556 | biostudies-literature
UnknownComparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial.
Not available
S-EPMC2833234 | biostudies-literature
UnknownPhase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
Not available
S-EPMC8522798 | biostudies-literature
UnknownAbacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.
Not available
S-EPMC2800041 | biostudies-literature
UnknownHepB-CpG Vaccine in People With HIV and Prior Nonresponse to HBV Vaccine: The BEe-HIVe Trial End-of-Study Results.
Not available
S-EPMC12224048 | biostudies-literature
UnknownHepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse: The BEe-HIVe Randomized Clinical Trial.
Not available
S-EPMC11610526 | biostudies-literature
Sort   by:  
 Page size